![](/img/cover-not-exists.png)
Safety and efficacy of 48 and 96 weeks of alendronate in children and adolescents with perinatal HIV infection and low bone mineral density for age
Lindsey, J C, Jacobson, D L, Spiegel, H, Gordon, C M, Hazra, R, Siberry, G KJournal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciaa861
Date:
June, 2020
File:
PDF, 603 KB
2020